Cargando…

Validation of a Predictive Model for Survival in Patients With Advanced Cancer: Secondary Analysis of RTOG 9714

BACKGROUND: The objective of this study was to validate a simple predictive model for survival of patients with advanced cancer. METHODS: Previous studies with training and validation datasets developed a model predicting survival of patients referred for palliative radiotherapy using three readily...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chow, Edward, James, Jennifer L., Hartsell, William, Scarantino, Charles W., Ivker, Robert, Roach, Mack, III, Suh, John H., Demas, William, Konski, Andre, Bruner, Deborah Watkins
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649656/ https://www.ncbi.nlm.nih.gov/pubmed/29147245 http://dx.doi.org/10.4021/wjon325w

Ejemplares similares

Sentinel lymph node imaging guided IMRT for prostate cancer: Individualized pelvic radiation therapy versus RTOG guidelines
por: Chen, Chien P., et al.
Publicado: (2015)

Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610
por: Pan, Larry, et al.
Publicado: (2013)

Web based pathology assessment in RTOG 98-04
por: Woodward, Wendy A, et al.
Publicado: (2014)

Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825
por: Patil, Nirav, et al.
Publicado: (2021)

Changes in post-treatment cardiac PET avidity predict overall survival in lung cancer patients treated with chemoradiation: Secondary analysis of the ACRIN 6668/RTOG 0235 clinical trial
por: Miller, Ryan, et al.
Publicado: (2022)

Survival and Toxicities of IMRT Based on the RTOG Protocols in Patients with Nasopharyngeal Carcinoma from the Endemic Regions of China
por: Liang, Shao-Bo, et al.
Publicado: (2017)

Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415
por: Khairnar, Rahul, et al.
Publicado: (2021)

Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617
por: Jin, Jian-Yue, et al.
Publicado: (2021)

Effect of RTOG breast/chest wall guidelines on dose‐volume histogram parameters
por: Rudra, Sonali, et al.
Publicado: (2014)

Human monkeypox hits beleaguered Zaire
por: Ivker, Robert
Publicado: (1997)

Clinical and dosimetric experience with MammoSite‐based brachytherapy under the RTOG 0413 protocol
por: Wojcicka, Jadwiga B., et al.
Publicado: (2007)

Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial
por: Feng, Felix Y., et al.
Publicado: (2021)

Cost effectiveness of prostate cancer radiotherapy
por: Konski, Andre
Publicado: (2018)

Thromboembolic Events Associated with Thalidomide and Multimodality Therapy for Soft Tissue Sarcomas: Results of RTOG 0330
por: Kane, J. M., et al.
Publicado: (2012)

The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Trials 9708 and 9905
por: Lee, Larissa J., et al.
Publicado: (2014)

Nodal recurrence patterns on PET/CT after RTOG-based nodal radiotherapy for prostate cancer
por: Liskamp, C.P., et al.
Publicado: (2020)

Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704
por: Regine, William F., et al.
Publicado: (2018)

RTOG 0518: Randomized Phase III Trial to Evaluate Zoledronic Acid for Prevention of Osteoporosis and Associated Fractures in Prostate Cancer Patients
por: Kachnic, Lisa A., et al.
Publicado: (2013)

Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable: A Secondary Analysis of the RTOG 9408 Randomized Clinical Trial
por: Zumsteg, Zachary S., et al.
Publicado: (2020)

Evaluation of Acuros XB algorithm based on RTOG 0813 dosimetric criteria for SBRT lung treatment with RapidArc
por: Rana, Suresh, et al.
Publicado: (2014)

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408
por: Nichols, R. Charles, et al.
Publicado: (2017)

An analysis of prognostic factors in a cohort of low-grade gliomas and degree of consistency between RTOG and EORTC scores
por: Pérez, Isaura Fernández, et al.
Publicado: (2022)

Association of Pretreatment Hippocampal Volume With Neurocognitive Function in Patients Treated With Hippocampal Avoidance Whole Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology/RTOG 0933
por: Abraham, Christopher D., et al.
Publicado: (2021)

Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities
por: Xiao, Canhua, et al.
Publicado: (2018)

Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial
por: Krayenbuehl, J., et al.
Publicado: (2017)

Prostate Stereotactic Body Radiation Therapy With Halcyon 2.0: Treatment Plans Comparison Based on RTOG 0938 Protocol
por: Altundal, Yücel, et al.
Publicado: (2020)

Clinical Outcomes of RTOG 9310 Protocol for Primary Central Nervous System Lymphoma: Single-Center Experience with 87 Patients
por: Kim, Jinuk, et al.
Publicado: (2021)

Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825
por: Scheurer, Michael E, et al.
Publicado: (2022)

Proposal of a post-prostatectomy clinical target volume based on pre-operative MRI: volumetric and dosimetric comparison to the RTOG guidelines
por: Croke, Jennifer, et al.
Publicado: (2014)

Correction to: Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial
por: Krayenbuehl, J., et al.
Publicado: (2017)

Creation of RTOG compliant patient CT-atlases for automated atlas based contouring of local regional breast and high-risk prostate cancers
por: Velker, Vikram M, et al.
Publicado: (2013)

Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy
por: Pokhrel, Damodar, et al.
Publicado: (2016)

Planning quality and delivery efficiency of sMLC delivered IMRT treatment of oropharyngeal cancers evaluated by RTOG H‐0022 dosimetric criteria
por: Zhu, X. Ronald, et al.
Publicado: (2004)

Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529
por: Mitra, Devarati, et al.
Publicado: (2017)

Differences in lower cranial nerve complications predicted by the NTCP model between RTOG and reduced-volume IMRT planning in radiotherapy for nasopharyngeal carcinoma
por: Qian, Jianjun, et al.
Publicado: (2020)

Quantitative assessments of late radiation-induced skin and soft tissue toxicity and correlation with RTOG scales and biological equivalent dose in breast cancer
por: Huang, Y., et al.
Publicado: (2021)

Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
por: Lassman, Andrew B., et al.
Publicado: (2022)

NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma
por: Batchelor, Tracy T, et al.
Publicado: (2023)

Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC
por: Giaddui, Tawfik, et al.
Publicado: (2016)

RADI-04. PRETREATMENT VOLUME OF MRI-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS COGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY RTOG 0933
por: Bovi, Joseph, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j92anpsbq1pfsaksg1s03oblb4